Solesta Product definition

Solesta Product means the product as defined in the License Agreement and more specifically described on Schedule B hereto, as Schedule B may be amended from time to time in accordance with Section 2.3 of this Agreement.
Solesta Product means the product containing a biocompatible gel composition formed from polymerized and cross-linked hyaluronic acid and dextranomer microspheres, wherein the hyaluronic acid is derived from non-animal sources, that is a formulation contained in a disposable syringe, as more specifically described on Schedule B attached to the QMS Supply Agreement, and as such Schedule B may be amended from time to time in accordance with Section 2.3 of the QMS Supply Agreement. Schedule B includes descriptions of the Solesta Product (i) as sold by Q-Med on the Effective Date and (ii) as currently being used in the PMA Approval Clinical Trial with respect to the gel composition and as intended to be sold in the Territory.
Solesta Product shall have the meaning set forth in the QMSI License Agreement.

Examples of Solesta Product in a sentence

  • To Q-Med’s knowledge, none of the Q-Med IP, the Deflux Product or the Solesta Product infringes upon, misappropriates, or misuses the intellectual property rights of any Third Party.

  • The Parties agree that the immediately preceding sentence shall not apply to the current Solesta Product and its components.

  • Within [*] months of receipt of Regulatory Approval in the U.S., QMS shall cause the Market Launch for the Solesta Product (or any other time as the Parties may agree upon in writing and subject to receipt by QMS of launch supplies of the Solesta Product from Q-Med ordered under the QMS Supply Agreement).

  • Upon its issuance, Q-Med shall assign the Solesta Product PMA to QMS.

  • What both OCA and DFS rulemaking as well as the Attorney General's enforcement actions do show is that debt collection abuses are so widespread in New York State that several agencies have identified the need, and have taken steps, to ameliorate the problems.

  • Notwithstanding anything herein to the contrary, Q-Med will continue to conduct the ongoing Solesta PMA Approval Clinical Trial relating to obtaining Regulatory Approval for the Solesta Product in the U.S. and the Solesta PMCS Trial in a timely manner.

  • Q-Med will bear all Development Costs for all such current pre-clinical studies required to be conducted by the FDA relating to the approval of the first Solesta Product in the U.S. Should FDA require additional pre-clinical studies to be performed, the parties shall share the costs for such additional pre-clinical studies.

  • The Purchase Prices, as so determined for Licensed Products other than the Solesta Product and the Deflux Product, shall be subject to adjustment thereafter under Section 3.2.

  • For clarity, any pre-clinical and clinical activities associated with the first Solesta Product in the U.S., including the Solesta PMA Approval Clinical Trial, shall not be a Project.

  • QMS may terminate this Agreement, effective upon not less than [*] months’ prior written notice to Q-Med if all Regulatory Approvals necessary for marketing and sale of the Solesta Product in the U.S. have not been achieved by [*], or at any time upon not less than [*] month’s prior written notice to Q-Med given following the [*] anniversary of the Market Launch of the Solesta Product.


More Definitions of Solesta Product

Solesta Product means the product containing a biocompatible gel composition formed from polymerized and cross-linked hyaluronic acid and dextranomer microspheres, wherein the hyaluronic acid is derived from non-animal sources, that is a formulation contained in a disposable syringe.
Solesta Product means the product containing a biocompatible gel composition formed from polymerized and cross-linked hyaluronic acid and dextranomer microspheres, wherein the hyaluronic acid is derived from non-animal sources, that is a formulation contained in a disposable syringe, as more specifically described on Schedule B attached to the Ireland Supply Agreement, and as such Schedule B may be amended from time to time in accordance with Section 2.3 of the Ireland Supply Agreement. Schedule B includes descriptions of the Solesta Product (i) as sold by Q-Med on the Effective Date and (ii) as currently being used in the PMA Approval Clinical Trial with respect to the gel composition and as intended to be sold in the U.S.

Related to Solesta Product

  • Licensed Fields of Use means the fields of use identified in Appendix B.

  • Licensed Field means [***].

  • Marijuana product means marijuana as defined in 50-32-101 and marijuana-infused products

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Licensed Field of Use means all fields.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • SAP Products means Software, Documentation, SAP Materials, Services, Subscription Services, Cloud Services and Maintenance Services. “SAP SDK” means SAP software development kit that includes tools such as APIs, source code, redistributable files and instructions. “Services” means SAP’s then-current services offered under and described in detail in the applicable SAP PartnerEdge Model.

  • End product means those articles, materials, and supplies to be acquired under the contract for public use.

  • Marijuana products means concentrated marijuana products and marijuana products that are comprised of marijuana and other ingredients and are intended for use or consumption, such as, but not limited to, edible products, ointments, and tinctures.

  • Moroccan end product means an article that—

  • End Products as used in this clause, means those articles, materials, and supplies to be acquired for public use under this contract.

  • Hemp products means all products made from industrial hemp,

  • Royalty Product means, either (a) an Alnylam Royalty Product, or (b) an Inex Royalty Product.

  • Proprietary product means a manufactured component or other product that is produced by a private person. It may be protected by patent, trademark or copyright.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Competing Products means any product or service in existence or under development that competes with any product or service of the Company Group about which the Participant obtained Confidential Information or for which the Participant provided advisory services or had sales, origination, marketing, production, distribution, research or development responsibilities in the last twenty-four (24) months of employment with the Company Group.

  • Generic Product means a product which (a) contains as its active pharmaceutical ingredient a compound that is (or is substantially the same as) the Licensed Compound, and (b) has been placed on the market pursuant to a validly granted marketing authorization.

  • Tobacco product means any substance containing tobacco leaf, including but not limited to, cigarettes, cigars, pipe tobacco, hookah tobacco, snuff, chewing tobacco, dipping tobacco, bidis, blunts, clove cigarettes, or any other preparation of tobacco; and any product or formulation of matter containing biologically active amounts of nicotine that is manufactured, sold, offered for sale, or otherwise distributed with the expectation that the product or matter will be introduced into the human body by inhalation; but does not include any cessation product specifically approved by the U.S. Food and Drug Administration for use in treating nicotine or tobacco dependence.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Territory means worldwide.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Licensed Territory means worldwide.

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • Cannabis products means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Competing Product means [***].

  • Commercialized shall have corresponding meanings.